Profit finally in sight for gene therapy specialist Oxford Bio – Reuters – Reuters
|
Profit finally in sight for gene therapy specialist Oxford Bio – Reuters
Reuters After 20 years of losses, gene therapy specialist Oxford BioMedica is at last close to achieving its first profit thanks to the success of Novartis with a pioneering … |
